Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration

Prospective use of amniotic mesenchymal stem cell metabolite products for tissue regeneration

Abstract Chronic disease can cause tissue and organ damage constituting the largest obstacle to therapy which, in turn, reduces patients’ quality-adjusted life-year. Degenerative diseases such as osteoporosis, Alzheimer’s disease, Parkinson’s disease, and infectious conditions such as hepatitis, cau...

Full description

Bibliographic Details
Main Authors: Andang Miatmoko, Berlian Sarasitha Hariawan, Devy Maulidya Cahyani, Syarifah Sutra Dewangga, Kevin Ksatria Handoko, Purwati, Ram Kumar Sahu, Dewi Melani Hariyadi
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Journal of Biological Engineering
Subjects:
Quality-adjusted life-year
Amniotic mesenchymal stem cell metabolite products
Growth factors
Tissue injury
Stem cells
Molecular therapy
Online Access:https://doi.org/10.1186/s13036-023-00331-1

Internet

https://doi.org/10.1186/s13036-023-00331-1

Similar Items